Ambrish Singh

Publications

• Global Prevalence of COVID-19-Associated Mucormycosis (CAM): Living Systematic Review and Meta-Analysis
• Proton pump inhibitors use and risk of preeclampsia
• Association of Acute Kidney Injury with the Risk of Dementia: A Meta-Analysis
• Global, regional, and national burden of diseases and injuries for adults 70 years and older: systematic analysis for the Global Burden of Disease 2019 Study
• Beta-adrenergic drugs and risk of Parkinson?s disease: A systematic review and meta-analysis
• Burden of osteoarthritis in India and its states, 1990–2019: findings from the Global Burden of disease study 2019
• ASSOCIATION BETWEEN KNEE MR IMAGING MARKERS AND KNEE SYMPTOMS OVER 7 YEARS IN YOUNG ADULTS
• Efficacy and safety of hydroxychloroquine in osteoarthritis: a systematic review and meta- analysis of randomized controlled trials
• Association between osteoarthritis-related serum biochemical markers over 11 years and knee MRI-based imaging biomarkers in middle-aged adults
• Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019
• Response to the letter to editor by Chen et al. regarding: Burden of osteoarthritis in India and its states, 1990–2019: findings from the Global Burden of Disease Study 2019
• Efficacy and safety of colchicine for the treatment of osteoarthritis: a systematic review and meta-analysis of intervention trials
• A Randomised Controlled Trial of YOGa and Strengthening Exercise for Knee OsteoArthritis: Protocol for a Comparative Effectiveness Trial (YOGA Trial)
• Protocol for a systematic review and meta-analysis of minimal important differences for generic multiattribute utility instruments
• EFFICACY AND SAFETY OF COLCHICINE FOR THE TREATMENT OF OSTEOARTHRITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF INTERVENTION TRIALS
• Trajectory of metabolic syndrome and its association with knee pain in middle-aged adults
• The burden and trend of diseases and their risk factors in Australia, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019
• Association between trajectory of metabolic syndrome and knee pain over 11 years in middle-aged adults: Evidence from childhood determinants of adult health (CDAH) study
• How Effective Are Non-Operative Intra-Articular Treatments for Bone Marrow Lesions in Knee Osteoarthritis in Adults? A Systematic Review of Controlled Clinical Trials
• Effect of Curcuma longa extract on serum inflammatory markers and MRI-based synovitis in knee osteoarthritis: secondary analyses from the CurKOA randomised trial
• Association Between Metabolic Syndrome And Knee Pain Over 10-13 Years In Middle-Aged Adults
• The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019
• Cost-effectiveness of regorafenib in the treatment of advanced hepatocellular carcinoma in Canada
• Chapter 10 Magnetic resonance imaging and biochemical markers of cartilage disease
• Impact of Pain on Activities of Daily Living in Older Adults: A Cross-Sectional Analysis of Korean Longitudinal Study of Aging (KLoSA)
• OP14 Cost-Utility Analysis Of Regorafenib For Patients With Hepatocellular Carcinoma Who Progressed On Sorafenib Treatment
• Pre-COVID life expectancy, mortality, and burden of diseases for adults 70 years and older in Australia: a systematic analysis for the Global Burden of Disease 2019 Study
• EFFECT OF CURCUMA LONGA EXTRACT ON INFLAMMATORY MARKERS AND FACTORS PREDICTING TREATMENT RESPONSE IN KNEE OSTEOARTHRITIS
• A systematic review of cost-effectiveness analyses of continuous versus intermittent renal replacement therapy in acute kidney injury
• Association between knee symptoms, change in knee symptoms over 6–9 years, and SF-6D health state utility among middle-aged Australians
• The burden of osteoarthritis across the states of India, 1990-2019: Findings from the global burden of disease study 2019
• Global Burden of Cardiovascular Diseases and Risks, 1990-2022
• Beta-agonists and risk of Parkinson's disease: Metaanalysis of Pharmacoepidemiological studies
• Proton pump inhibitors use and risk of preeclampsia: A meta-analysis of pharmacoepidemiological studies
• Burden of diabetes and hyperglycaemia in adults in the Americas, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019
• Boswellia for osteoarthritis (Protocol)
• Proton pump inhibitor use and the risk of hepatocellular carcinoma: A systematic review of pharmacoepidemiological data
• Global, regional, and national burden of other musculoskeletal disorders, 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
• Association Between Metabolic Syndrome and Knee Pain over 10-13 Years in Middle-Aged Adults
• ASSOCIATION BETWEEN KNEE MR IMAGING MARKERS AND KNEE SYMPTOMS OVER 7 YEARS IN YOUNG ADULTS
• THE BURDEN OF OSTEOARTHRITIS ACROSS THE STATES OF INDIA, 1990-2019: FINDINGS FROM THE GLOBAL BURDEN OF DISEASE STUDY 2019
• THE BURDEN OF OSTEOARTHRITIS ACROSS THE STATES OF INDIA, 1990-2019: FINDINGS FROM THE GLOBAL BURDEN OF DISEASE STUDY 2019
• Global, regional, and national burden of low back pain, 1990-2020, its attributable risk factors, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
• Global, regional, and national burden of osteoarthritis, 1990-2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021
• Global, regional, and national burden of rheumatoid arthritis, 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
• Global, regional, and national burden of neck pain, 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
• Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
• Global pattern, trend, and cross-country inequality of early musculoskeletal disorders from 1990 to 2019, with projection from 2020 to 2050
• 810 COMPARATIVE EFFECTIVENESS OF YOGA AND STRENGTHENING EXERCISE FOR TREATING KNEE OSTEOARTHRITIS: A RANDOMISED CONTROLLED TRIAL (YOGA TRIAL)
• Proton Pump Inhibitors Use and Risk of Preeclampsia: A Meta-Analysis
• Prevalence and Clinical Significance of Residual or Reconverted Red Bone Marrow on Knee MRI
• No association between proton pump inhibitor use and risk of dementia: Evidence from a meta‐analysis
• A RANDOMISED PLACEBO-CONTROLLED CLINICAL TRIAL OF CURCUMA LONGA EXTRACT FOR TREATING SYMPTOMS AND EFFUSION-SYNOVITIS OF KNEE OSTEOARTHRITIS
• EFFICACY AND SAFETY OF HYDROXYCHLOROQUINE FOR THE TREATMENT OF OSTEOARTHRITIS A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
• Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019
• A RANDOMISED PLACEBO-CONTROLLED CLINICAL TRIAL OF CURCUMA LONGA EXTRACT FOR TREATING SYMPTOMS AND EFFUSION-SYNOVITIS OF KNEE OSTEOARTHRITIS (CURKOA TRIAL)
• ASSOCIATION BETWEEN OSTEOARTHRITIS-RELATED SERUM BIOCHEMICAL MARKERS OVER 11 YEARS AND KNEE MRI-BASED IMAGING BIOMARKERS IN MIDDLE-AGED ADULTS
• Nicotinamide Therapy in Dialysis Patients: A Systematic Review of Randomized Controlled Trials
• A RANDOMISED PLACEBO-CONTROLLED CLINICAL TRIAL OF CURCUMA LONGA EXTRACT FOR TREATING SYMPTOMS AND EFFUSION-SYNOVITIS OF KNEE OSTEOARTHRITIS (CURKOA TRIAL)
• ASSOCIATION BETWEEN OSTEOARTHRITIS-RELATED SERUM BIOCHEMICAL MARKERS OVER 11 YEARS AND KNEE PAIN IN MIDDLE-AGED ADULTS
• Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019 Update From the GBD 2019 Study
• ASSOCIATION BETWEEN KNEE MRI MARKERS AND KNEE SYMPTOMS OVER 7 YEARS IN YOUNG ADULTS
• Association between knee symptoms, change in knee symptoms over 6-9 years and SF-6D health state utility among middle-aged Australians
• ASSOCIATION BETWEEN OSTEOARTHRITIS-RELATED SERUM BIOMARKERS OVER 11 YEARS AND KNEE MRI-BIOMARKERS IN MIDDLE-AGED ADULTS
• Impact of Multisite Pain on Activities of Daily Living in Older Adults: A Cross-sectional Analysis of Korean Longitudinal Study of Ageing (KLoSA)
• Beta-adrenoceptor antagonists and risk of Parkinson's disease: Meta-analysis of pharmacoepidemiological studies
• Efficacy and Safety of Turmeric Extracts for the Treatment of Knee Osteoarthritis: a Systematic Review and Meta-analysis of Randomised Controlled Trials
• Proton pump inhibitor use and the risk of hepatocellular carcinoma: A systematic review of real-world data
• ASSOCIATION OF ACUTE KIDNEY INJURY WITH THE RISK OF DEMENTIA: A META-ANALYSIS OF EPIDEMIOLOGICAL STUDIES
• Measuring routine childhood vaccination coverage in 204 countries and territories, 1980-2019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1
• Spatial, temporal, and demographic patterns in prevalence of chewing tobacco use in 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019
• Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019
• Mapping geographical inequalities in access to drinking water and sanitation facilities in low-income and middle-income countries, 2000-17
• Non-alcoholic fatty liver disease and clinical outcomes in patients with COVID-19: A comprehensive systematic review and meta-analysis.
• Imaging and Biochemical Markers for Osteoarthritis
• Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017
• PMS6 Association between Knee Symptoms, Change in Knee Symptoms over 6–9 YEARS and SF-6D Health State Utility Among Middle-Aged Australians
• Five insights from the Global Burden of Disease Study 2019
• Mapping geographical inequalities in oral rehydration therapy coverage in low-income and middle-income countries, 2000-17
• Beta-adrenoceptor antagonists and risk of Parkinson's disease: Meta-analysis of pharmacoepidemiological studies
• ASSOCIATION BETWEEN KNEE SYMPTOMS, CHANGE IN KNEE SYMPTOMS OVER 6-9 YEARS AND SF-6D HEALTH STATE UTILITY AMONG MIDDLE-AGED AUSTRALIANS
• Impact of Multisite Pain on Activities of Daily Living in Older Adults: A Cross-sectional Analysis of Korean Longitudinal Study of Ageing (KLoSA) (1706)
• Author Correction: Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017 (Nature Medicine, (2020), 26, 5, (750-759), 10.1038/s41591-020-0807-6)
• Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019
• ASSOCIATION BETWEEN OSTEOARTHRITIS-RELATED SERUM BIOCHEMICAL MARKERS OVER 11 YEARS AND KNEE SYMPTOMS IN MIDDLE-AGED ADULTS
• Comment on: “Cost Effectiveness of Dialysis Modalities: A Systematic Review of Economic Evaluations”
• Efficacy and safety of tocilizumab in treatment of Takayasu arteritis: A systematic review of randomized controlled trials
• Efficacy and safety of turmeric extracts in knee osteoarthritis: protocol for a systematic review and meta-analysis of randomised controlled trials
• Early life modifiable risk factors for the development of knee osteoarthritis: protocol for a systematic review
• Efficacy and safety of hydroxychloroquine for the treatment of osteoarthritis: protocol for a systematic review of randomized controlled trials
• Efficacy and safety of Boswellia containing formulations for the treatment of osteoarthritis: protocol for a systematic review and meta-analysis of randomised controlled trials
• Effectiveness of Curcuma longa Extract for the Treatment of Symptoms and Effusion–Synovitis of Knee Osteoarthritis
• Clinical Characteristics, Treatments, and Concurrent Mutations in Non–Small Cell Lung Cancer Patients With NF1 Mutations
• Thiazolidinedione use is associated with reduced risk of Parkinson's disease in patients with diabetes: a meta-analysis of real-world evidence
• Effects of walnut intake on blood pressure: a systematic review and meta-analysis of randomized controlled trials
• Effects of Phytosterols supplementation on blood glucose, glycosylated hemoglobin (HbA1c) and insulin levels in humans: a systematic review and meta-analysis of randomized controlled trials
• Systematic Review and Meta-Analysis Protocol: Beta adrenoreceptor drugs and risk of Parkinson’s disease
• Association of acute kidney injury with the risk of dementia: A meta-analysis protocol
• Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019
• Is it about the 'where' or thSare 'how'? Comment on Defining global health as public health somewhere else
• Letter to the editor on the article “The effect of vitamin D supplementation on knee osteoarthritis: A meta-analysis of randomized controlled trials”
• Vitamin D supplementation for the management of knee osteoarthritis: a systematic review of randomized controlled trials
• Prevalence of Depression Among Type 2 Diabetes Mellitus Patients in India: Evidence-Based Systematic Review and Meta Analysis
• Tadalafil in Benign Prostatic Hyperplasia: Protocol for the Systematic Review of Adverse Events
• Efficacy and Safety of Tocilizumab in Treatment of Takayasu Arteritis: a Systematic Review of Randomized Controlled Trials
• Epistemonikos: A database not to be missed while searching systematic reviews
• Role Of Budget Impact Analysis In Market Access Of Biosimilars.
• Insurance Coverage Policies for Companion Diagnostics in Breast Cancer
• Tadalafil in Benign Prostatic Hyperplasia: Protocol for the Systematic Review of Adverse Events
• Influence of Cochrane Evidence on Medical Policies of Oncology Drugs in the United States
• Calcium channel blocker use reduces incident dementia risk in elderly hypertensive patients: A meta-analysis of prospective studies
• Private Payers' Medical Policies Influenced by Cochrane Evidence?
• Proton pump inhibitors use and risk of chronic kidney disease: Evidence-based meta-analysis of observational studies
• How Odd is Odds Ratio to Understand and How Risky is Risk Ratio to Interpret?
• Clinically meaningful improvement (CMI) in SF-36 vitality scale for methotrexate (MTX)-naive patients with early, active rheumatoid arthritis (RA)
• Insurance Coverage Policies for Companion Diagnostics in Breast Cancer
• SYSTEMATIC REVIEW OF HEALTH-ECONOMIC ANALYSES OF CONTINUOUS VERSUS INTERMITTENT RENAL REPLACEMENT THERAPY IN PATIENTS WITH ACUTE KIDNEY INJURY
• How odd is odds ratio to understand and how risky is risk ratio to interpret?
• Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 2006 to 2016: A systematic analysis for the Global Burden of Disease study
• Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017 A Systematic Analysis for the Global Burden of Disease Study
• Impact and correlates of early knee osteoarthritis
• Use of Cochrane evidence in supporting medical policies of oncology drugs in the United States
• Prevalence of Depression Among Type 2 Diabetes Mellitus Patients in India: Evidence-Based Systematic Review and Meta Analysis
• Efficacy and safety of colchicine for the treatment of osteoarthritis: protocol for a systematic review and meta-analysis of intervention trials
• PD53 Efficacy And Safety Of Nicotinamide In Hemodialysis Patients
• Metformin use and risk of dementia: A meta-analysis of observational studies
• How odd is odds ratio to understand and how risky is risk ratio to interpret?
• Number of studies, heterogeneity, generalisability, and the choice of method for meta-analysis
• OP134 Pan-Canadian Oncology Drug Review Decisions And Access To Anticancer Treatments In Canada
• MP347PROTON PUMP INHIBITORS USE AND THE RISK OF CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META ANALYSIS
• Role of Cochrane Reviews in informing US private payers’ policies
• Prevalence of depression among type 2 diabetes mellitus patients in India: A meta-analysis
• Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
• Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016 A Systematic Analysis for the Global Burden of Disease Study
• Adverse Drug Reactions in COVID-19 Patients: Protocol for a Living Systematic Review
• COMPARATIVE EFFECTIVENESS OF YOGA AND STRENGTHENING EXERCISE FOR TREATING KNEE OSTEOARTHRITIS: A RANDOMISED CONTROLLED TRIAL (YOGA TRIAL)
• Association between osteoarthritis-related serum biochemical markers over 10-13 years and knee symptoms in middle-aged adults
• Association between osteoarthritis-related serum biochemical markers over 10–13 years and knee symptoms in middle-aged adults
• EFFECT OF CURCUMA LONGA EXTRACT ON INFLAMMATORY MARKERS AND FACTORS PREDICTING TREATMENT RESPONSE IN KNEE OSTEOARTHRITIS
• Yoga or Strengthening Exercise for Knee Osteoarthritis
• ASSOCIATION BETWEEN METABOLIC SYNDROME AND KNEE PAIN IN MIDDLE-AGED ADULTS OVER 10-13 YEARS
• ASSOCIATION BETWEEN TRAJECTORY OF METABOLIC SYNDROME AND KNEE PAIN OVER 11 YEARS IN MIDDLE-AGED ADULTS
• Comparative Effectiveness of Yoga and Strengthening Exercise for Treating Knee OsteoArthritis: A Randomised Controlled Trial (YOGA Trial)
• EFFICACY AND SAFETY OF CANNABIS EXTRACT FOR THE TREATMENT OF OSTEOARTHRITIS: A SYSTEMATIC REVIEW OF PRE-CLINICAL AND HUMAN STUDIES
• ASSOCIATION BETWEEN METABOLIC SYNDROME AND KNEE PAIN OVER 10-13 YEARS IN MIDDLE-AGED ADULTS